Answer
Yes, neostigmine methylsulfate should not be administered to patients with peritonitis or doubtful bowel viability.
Sources for this answer
- Neostigmine Methylsulfate Injection BP 2.5mg in 1mlhameln pharma ltd · emc · SmPC §4.3 Contraindications · Version 7Document updated
Sources checked